What is TB-500?
TB-500 is a synthetic peptide containing the active sequence (LKKTETQ) of Thymosin Beta-4 (Tβ4), a 43-amino acid protein found abundantly in both human and animal cells. Tβ4 is crucial for wound healing and cellular regeneration. TB-500 is synthesized to replicate these regenerative effects, specifically focusing on promoting cell migration, blood vessel growth, and tissue repair throughout the body.
How does TB-500 work?
The primary mechanism of TB-500 lies in its ability to sequester G-actin (monomeric actin). By binding to actin, it promotes actin polymerization, which is essential for cell structure, mobility, and migration. This enables cells (such as fibroblasts and endothelial cells) to travel rapidly to injured sites to initiate repair. TB-500 also upregulates matrix metalloproteinases, which assist in tissue remodeling and promote angiogenesis.
Primary Documented Uses
- Accelerating muscle, joint, and ligament repair
- Enhancing flexibility and range of motion post-injury
- Promoting hair growth and skin rejuvenation
- Supporting cardiovascular tissue recovery in research models
Research Summary
Scientific literature documents TB-500's efficacy in wound healing, corneal repair, and cardiovascular protection. In animal models, administration of Tβ4/TB-500 significantly accelerates dermal healing, reduces scar tissue formation, and improves cardiac function post-myocardial infarction. Like BPC-157, most data is pre-clinical, with human trials limited to specific corneal and dermal healing applications.
Legal and Regulatory Status
TB-500 is not approved by the FDA for human use. It is banned by the World Anti-Doping Agency (WADA) under class S2 (Peptide Hormones and Mimetic Substances). Compounding pharmacies are restricted from distributing TB-500 for human clinical therapies; it is legally sold only as a research chemical.
Frequently Asked Questions
What is TB-500?
TB-500 is A synthetic fraction of the naturally occurring peptide Thymosin Beta-4, known for its powerful role in cellular migration and tissue repair.
How does TB-500 work?
The primary mechanism of TB-500 lies in its ability to sequester G-actin (monomeric actin). By binding to actin, it promotes actin polymerization, which is essential for cell structure, mobility, and migration. This enables cells (such as fibroblasts and endothelial cells) to travel rapidly to injured sites to initiate repair. TB-500 also upregulates matrix metalloproteinases, which assist in tissue remodeling and promote angiogenesis.
What does research say about TB-500?
Scientific literature documents TB-500's efficacy in wound healing, corneal repair, and cardiovascular protection. In animal models, administration of Tβ4/TB-500 significantly accelerates dermal healing, reduces scar tissue formation, and improves cardiac function post-myocardial infarction. Like BPC-157, most data is pre-clinical, with human trials limited to specific corneal and dermal healing applications.
Is TB-500 FDA-approved or legally available?
TB-500 is not approved by the FDA for human use. It is banned by the World Anti-Doping Agency (WADA) under class S2 (Peptide Hormones and Mimetic Substances). Compounding pharmacies are restricted from distributing TB-500 for human clinical therapies; it is legally sold only as a research chemical.